世界の電子処方市場 – 2030 年までの業界動向と予測

Get Exclusive Sample PDF of this Report Here

電子処方箋市場の分析と規模

世界中で電子処方箋の必要性が高まっているのは、医療のさまざまな側面でテクノロジーの利用が拡大しているためです。成長を促進するその他の技術開発には、より優れたパフォーマンスと導入の容易さを備えた製品の開発が含まれます。これらのソリューションは、手頃な価格のジェネリック製剤を提供することで、患者のコンプライアンスと組織のワークフローを向上させます。公衆衛生に配慮した政府政策の採用や医療システムの大幅なアップグレードなど、業界を活性化させる要因がさらに見込まれています。これらすべての要因が市場の成長に貢献します。

Data Bridge Market Researchは、2022年に17億7,000万米ドルであった電子処方市場は、2030年までに84億1,000万米ドルに急増し、2023年から2030年の予測期間中に21.5％のCAGRを達成すると分析しています。市場価値、成長率、市場セグメント、地理的範囲、市場プレーヤー、市場シナリオなどの市場洞察に加えて、Data Bridge Market Researchチームがまとめた市場レポートには、詳細な専門家分析、患者の疫学、パイプライン分析、価格分析、規制枠組みも含まれています。

電子処方箋市場の範囲とセグメンテーション  

Get Exclusive Sample PDF of this Report Here

市場の定義

電子処方箋とも呼ばれる電子処方箋は、医師やその他の医療従事者が、手書きやファックスのメモを使用したり、処方箋を電話で伝えたりするのではなく、電子的に処方箋を書いて参加薬局に送信できるようにする技術的なフレームワークです。電子処方箋とも呼ばれる電子処方箋は、医療提供者がデジタル処方箋を作成できるようにする Web またはクラウドベースのソリューションです。これは、正確な処方箋を作成して病院内または独立薬局に送信するコンピューターベースのプロセスです。電子処方箋ソフトウェアは、処方箋を自動的に補充し、患者の履歴に基づいて投薬を管理し、電子医療記録 (EMR) システムと統合できます。

電子処方市場の動向

ドライバー

• EHRソリューションの採用増加

EHR ソリューションの必要性は、主に政府による EHR ソリューション導入への支援拡大によって推進されています。電子健康記録の導入により、処方箋の記入がいくつかの点で簡素化されました。統合ソリューションは、スタンドアロンの電子処方システムよりも病歴の可用性が向上します。COVID-19 の世界的な流行により、病院の患者数も増加し、患者データの管理を改善する必要が生じています。これにより、これらのソリューションの需要が高まると予想されます。

• 病院での電子処方箋の増加

処方箋がよりハイテク化されるにつれ、医師は、医療において基本的でありながら極めて重要なものに代わるテクノロジーをよりよく備えていることに気づき始めています。コンピューターが医療処方箋を作成し、通信し、ファイルすることを「電子処方箋」と呼びます。その主な目的は、紙の処方箋の必要性と処方ミスの危険性を減らすことです。これらが市場の成長を促進する要因です。

機会

• 電子処方技術の開発

The main issue fuelling the development of e-prescribing technologies is the escalating opioid crisis in the United States. While making it more challenging to engage in misuse or fraud, the electronic prescription in controlled medications (EPCS) system offers a transparent, secure method that makes it relatively simpler to prescribe various controlled substances to patients who genuinely require them. For instance, the opioid issue reached crisis proportions in 2018 and cost the United States more than USD 500 billion annually, according to surescipt projections.

Restraints/Challenges

• High cost of employment

The high cost of employment, security, and workflow issues and the increasing use of e-prescribing systems will obstruct the market's growth rate. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the eprescribing market.

The cost is not limited to only one time of purchase of system but also include recurrent expenses such as maintenance and support services.

This ePrescribing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the ePrescribing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on ePrescribing Market

The COVID-19 pandemic won't have a direct effect on the ePrescribing market, but it will have an impact on the healthcare IT and EMR businesses, which will increase demand for e-prescribing tools both during and after the pandemic. The COVID-19 outbreak has led to an upsurge in teleconsultations. EHR, telemedicine, and e-prescribing functions are integrated to let prescribers build an interconnected network that ensures the usage of HCIT for patient diagnosis and medication prescription. The Drug Enforcement Administration's (DEA) rules permitting electronic prescription of restricted substances have also increased the frequency of electronic prescription transactions, as have the CDC's advice to use telemedicine services.

Recent Development

• In April 2020, DrFirst (US) partnered with ID.me (US) to help users of the company’s e-prescribe app to verify their identities within a few minutes. This is predictable to speed up the process for clinicians to prescribe drugs.
• In July 2019, NextGen Healthcare(US) announced its partnership with Optimize Rx (US) to provide real-time access to critical financial information, allowing providers to help patients choose appropriate medication plans per their coverage and budgets. This tool has been integrated with the company’s EHR workflow.
• In June 2019, Allscripts (US) acquired ZappRx (US) to help Veradigm’s e-prescribing solutions by integrating it with the automated prior authorization platform, thus adding value to its existing platform. 

Global ePrescribing Market Scope

The ePrescribing market is segmented on the basis of product, usage mode, component, type of system, mode of delivery, substances, specialties and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Solutions
• Services
• Support
• Implementation
• Training
• Network

Component

• Hardware
• Software
• Services

 Type of System

• Stand-alone E-prescribing System
• Integrated E-prescribing System

 Usage Mode

• Handheld Device
• Computer-Based Devices

Mode of Delivery

• Web and Cloud-Based Solutions
• On-Premise Solutions

 Substances

• Controlled Substances
• Non-Controlled Substances

Specialties

• Oncology
• Sports Medicine
• Neurology
• Cardiology
• Others

 End-User

• Clinics
• Physicians
• Pharmacies
• Hospitals

ePrescribing Market Regional Analysis/Insights

The ePrescribing market is analyzed and market size insights and trends are provided by country, product, usage mode, component, type of system, mode of delivery, substances, specialties and end-user as referenced above.

The countries covered in the ePrescribing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the ePrescribing market owing to high number of government initiatives and incentives in the region.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to the rising health awareness among the people and growing demand of advanced medical technology.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and ePrescribing Market Share Analysis

The ePrescribing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to ePrescribing market.

Some of the major players operating in the ePrescribing market are:

• Epic Systems Corporation (U.S.)
• Cerner Corporation (U.S.)
• Allscripts Healthcare, LLC. (U.S.)
• NXGN Management, LLC. (U.S.)
• athenahealth, Inc. (U.S.)
• RelayHealth, LLC (U.S.)
• Henry Schein, Inc. (U.S.)
• General electric (U.S.)
• CPSI (U.S.)
• DrFirst (U.S.)
• Medical Information Technology, Inc. (U.S.)
• eClinicalWorks (U.S.)

Research Methodology: Global ePrescribing Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合ったデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、再開発市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社を必要なだけ追加し、必要な形式とデータ スタイルでデータを作成できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクトブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。

SKU-56812